Granted Patent
B2
US 8,003,679 · App. 11/441,648 · Granted Aug 23, 2011
Use of inhibitors of the renin-angiotensin system
Assignee:
ArkTherapeutics Group, plc
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Inhibitors of the rennin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia, such as stroke.
Claims (2)
1. A method for the treatment or prevention of stroke, wherein said method comprises administering, to a human patient diagnosed as in need of such treatment or prevention of stroke, in an amount effective for the treatment or prevention of stroke, telmisartan, wherein said patient is a normotensive or hypotensive human patient.
2. The method of claim 1 , said wherein said patient is a male.
Assignments (4)
RELEASE OF SECURITY INTEREST
Recorded Jan 31, 2022
From: PHARMACEUTICAL PATENT ATTORNEYS, LLC
To: TRIZELL LTD., F/K/A FINVECTOR LTD. F/K/A ARK THERAPEUTICS LTD.
Reel/Frame 058826/0044 →
SECURITY INTEREST
Recorded Nov 19, 2020
From: TRIZELL LTD.
To: PHARMACEUTICAL PATENT ATTORNEYS, LLC
Reel/Frame 054775/0546 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 30, 2012
From: ARK THERAPEUTICS LIMITED
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 028125/0459 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 23, 2012
From: MONTGOMERY, HUGH EDWARD; MARTIN, JOHN FRANCIS; ERUSALIMSKY, JORGE DANIEL
To: ARK THERAPEUTICS LIMITED
Reel/Frame 028087/0832 →
Continuity (6)
Continuation
09529628
Provisional Application
60067819
· Dec 5, 1997
Provisional Application
60094902
· Jul 31, 1998